S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
Log in
BATS:FFEB

FT Cboe Vest U.S. Equity Buffer ETF - February Stock Forecast, Price & News

$33.51
+0.07 (+0.21 %)
(As of 01/25/2021 12:00 AM ET)
Add
Today's Range
$33.33
Now: $33.51
$33.52
50-Day Range
$32.67
MA: $33.07
$33.48
52-Week Range N/A
Volume109,576 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A


Basic Details

Issuer First Trust
Fund NameFT Cboe Vest U.S. Equity Buffer ETF - February
Tax ClassificationRegulated Investment Company
SymbolBATS:FFEB
Inception Date2/21/2020
Fund ManagerKaran Sood, Howard Rubin
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
Benchmark
CategorySize and Style
FocusLarge Cap
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$246.83 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.85%
Other Expenses0.00%
Total Expenses0.85%
Fee Waiver0.00%
Net Expenses0.85%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorFirst Trust Advisors L.P.
CustodianThe Bank of New York Mellon Corporation
DistributorFirst Trust Portfolios L.P.
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market Maker
$33.51
+0.07 (+0.21 %)
(As of 01/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FFEB News and Ratings via Email

Sign-up to receive the latest news and ratings for FFEB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











FT Cboe Vest U.S. Equity Buffer ETF - February (BATS:FFEB) Frequently Asked Questions

How has FT Cboe Vest U.S. Equity Buffer ETF - February's stock been impacted by COVID-19 (Coronavirus)?

FT Cboe Vest U.S. Equity Buffer ETF - February's stock was trading at $26.81 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FFEB shares have increased by 25.0% and is now trading at $33.51.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than FT Cboe Vest U.S. Equity Buffer ETF - February?

Wall Street analysts have given FT Cboe Vest U.S. Equity Buffer ETF - February a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but FT Cboe Vest U.S. Equity Buffer ETF - February wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is FT Cboe Vest U.S. Equity Buffer ETF - February's stock symbol?

FT Cboe Vest U.S. Equity Buffer ETF - February trades on the BATS under the ticker symbol "FFEB."

Who are FT Cboe Vest U.S. Equity Buffer ETF - February's major shareholders?

FT Cboe Vest U.S. Equity Buffer ETF - February's stock is owned by a variety of institutional and retail investors. Top institutional investors include Janney Montgomery Scott LLC (0.00%) and We Are One Seven LLC (0.00%).

Which institutional investors are selling FT Cboe Vest U.S. Equity Buffer ETF - February stock?

FFEB stock was sold by a variety of institutional investors in the last quarter, including Janney Montgomery Scott LLC, and We Are One Seven LLC.

How do I buy shares of FT Cboe Vest U.S. Equity Buffer ETF - February?

Shares of FFEB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is FT Cboe Vest U.S. Equity Buffer ETF - February's stock price today?

One share of FFEB stock can currently be purchased for approximately $33.51.

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.